GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Genzyme has done it before with Genzyme tissue repair and GZMO. A little different because of tracking company status which we don't exactly have.<

Why did you insert the word exactly? GTCB is a company, not a tracking stock. Period.

>In theory Genz as a large corporate owner of GTCB stock…<

This is a common misconception. GENZ’s equity stake in GTCB is 3.5% on a diluted basis (#msg-26840492). They do have historical ties to GTCB but they are not what I would call a “large corporate owner.”

>…could [GENZ] be forcing downward pressure on the stock by selling now to perhaps get a better deal for atryn or take over.<

Ludicrous, IMO.